Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Drug Resistance

  Free Subscription


20.01.2020

17 Antimicrob Agents Chemother
2 Infect Control Hosp Epidemiol
5 Int J Antimicrob Agents
12 J Antimicrob Chemother
2 J Infect Dis
6 PLoS One
1 Sex Transm Infect


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. MILLER CR, Dey S, Smolenski PD, Kulkarni PS, et al
    Distinct Subpopulations of Intravalvular Methicillin-Resistant Staphylococcus aureus With Variable Susceptibility to Daptomycin in Tricuspid Valve Endocarditis.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.01593.
    PubMed     Text format     Abstract available

  2. ROTONDO CM, Sychantha D, Koteva K, Wright GD, et al
    Suppression of beta-Lactam Resistance by Aspergillomarasmine A is Influenced by Both the Metallo-beta-Lactamase Target and the Antibiotic Partner.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.01386.
    PubMed     Text format     Abstract available

  3. BIAGI M, Shajee A, Vialichka A, Jurkovic M, et al
    Activity of imipenem-relebactam and meropenem-vaborbactam against carbapenem-resistant SME-producing Serratia marcescens.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.02255.
    PubMed     Text format     Abstract available

  4. POIREL L, Ortiz De La Rosa JM, Kieffer N, Dubois V, et al
    Acquisition of Extended-Spectrum beta-Lactamase GES-6 Leading to Resistance to Ceftolozane-Tazobactam Combination in Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2018;63.
    PubMed     Text format     Abstract available

  5. SOLIMAN AM, Shimamoto T, Nariya H, Shimamoto T, et al
    Emergence of Salmonella Genomic Island 1 Variant SGI1-W in a Clinical Isolate of Providencia stuartii from Egypt.
    Antimicrob Agents Chemother. 2018;63.
    PubMed     Text format    

  6. PALACIOS AR, Mojica MF, Giannini E, Taracila MA, et al
    The Reaction Mechanism of Metallo-beta-Lactamases Is Tuned by the Conformation of an Active-Site Mobile Loop.
    Antimicrob Agents Chemother. 2018;63.
    PubMed     Text format     Abstract available

  7. JOHNSON TJ, Elnekave E, Miller EA, Munoz-Aguayo J, et al
    Phylogenomic Analysis of Extraintestinal Pathogenic Escherichia coli Sequence Type 1193, an Emerging Multidrug-Resistant Clonal Group.
    Antimicrob Agents Chemother. 2018;63.
    PubMed     Text format     Abstract available

  8. WANG Y, Mukhopadhyay R, Roy S, Kapoor A, et al
    Inhibition of Cytomegalovirus Replication with Extended Half-Life Synthetic Ozonides.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.01735.
    PubMed     Text format     Abstract available

  9. SHIELDS RK, Kline EG, Healey KR, Kordalewska M, et al
    Spontaneous mutational frequency and FKS mutation rates vary by echinocandin agent against Candida glabrata.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.01692.
    PubMed     Text format     Abstract available

  10. HUBER L, Giguere S, Slovis NM, Carter CN, et al
    Emergence of Resistance to Macrolides and Rifampin in Clinical Isolates of Rhodococcus equi from Foals in Central Kentucky, 1995 to 2017.
    Antimicrob Agents Chemother. 2018;63.
    PubMed     Text format     Abstract available

  11. CHOJNACKI M, Philbrick A, Wucher B, Reed JN, et al
    Development of a broad-spectrum antimicrobial combination for the treatment of Staphylococcus aureus and Pseudomonas aeruginosa corneal infections.
    Antimicrob Agents Chemother. 2018 Nov 12. pii: AAC.01929.
    PubMed     Text format     Abstract available

  12. GOODLET KJ, Benhalima FZ, Nailor MD
    A systematic review of single-dose aminoglycoside therapy for urinary tract infection: Is it time to resurrect an old strategy?
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.02165.
    PubMed     Text format     Abstract available

  13. DE MIRANDA SILVA C, Hajihosseini A, Myrick J, Nole J, et al
    Effect of Moxifloxacin plus Pretomanid against Mycobacterium tuberculosis in Log-phase, Acid-phase and Non-Replicating-Persister (NRP)-phase in an in vitro Assay.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01695.
    PubMed     Text format     Abstract available

  14. MONK BC, Keniya MV, Sabherwal M, Wilson RK, et al
    Azole Resistance Reduces Susceptibility to the Tetrazole Antifungal VT-1161.
    Antimicrob Agents Chemother. 2018;63.
    PubMed     Text format     Abstract available

  15. KARLOWSKY JA, Adam HJ, Baxter MR, Denisuik AJ, et al
    In Vitro Activity of Sulopenem, an Oral Penem, against Urinary Isolates of Escherichia coli.
    Antimicrob Agents Chemother. 2018;63.
    PubMed     Text format     Abstract available

  16. KOTSAKIS SD, Flach CF, Razavi M, Larsson DGJ, et al
    Characterization of the First OXA-10 Natural Variant with Increased Carbapenemase Activity.
    Antimicrob Agents Chemother. 2018;63.
    PubMed     Text format     Abstract available

  17. HOU X, Lee A, Jimenez-Ortigosa C, Kordalewska M, et al
    Rapid Detection of ERG11-Associated Azole Resistance and FKS-Associated Echinocandin Resistance in Candida auris.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01811.
    PubMed     Text format     Abstract available


    Infect Control Hosp Epidemiol

  18. SHENG T, Wijayaratne GB, Dabrera TM, Drew RJ, et al
    Point-prevalence study of antimicrobial use in public hospitals in southern Sri Lanka identifies opportunities for improving prescribing practices.
    Infect Control Hosp Epidemiol. 2019;40:224-227.
    PubMed     Text format     Abstract available

  19. DALMOLIN TV, Wink PL, de Lima-Morales D, Barth AL, et al
    Low prevalence of the mcr-1 gene among carbapenemase-producing clinical isolates of Enterobacterales.
    Infect Control Hosp Epidemiol. 2019;40:263-264.
    PubMed     Text format    


    Int J Antimicrob Agents

  20. LAU CH, DeJong EN, Dussault F, Carrillo C, et al
    A penicillin-binding protein that can promote advanced-generation cephalosporin resistance and genome adaptation in the opportunistic pathogen Pseudomonas aeruginosa.
    Int J Antimicrob Agents. 2020 Jan 9:105896.
    PubMed     Text format     Abstract available

  21. TUMBARELLO M, Raffaelli F, Peghin M, Losito AR, et al
    Characterisation and risk-factor profiling of P. aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains.
    Int J Antimicrob Agents. 2020 Jan 10:105900.
    PubMed     Text format     Abstract available

  22. BOCHAROVA Y, Savinova T, Lazareva A, Polikarpova S, et al
    Genotypes, carbapenemase carriage, integron diversity, and oprD alterations among carbapenem-resistant Pseudomonas aeruginosa from Russia.
    Int J Antimicrob Agents. 2020 Jan 10:105899.
    PubMed     Text format     Abstract available

  23. BRITT NS, Hazlett DS, Horvat RT, Liesman RM, et al
    Activity of Pulmonary Vancomycin Exposures versus Planktonic and Biofilm Methicillin-Resistant Staphylococcus aureus Isolated from Cystic Fibrosis Sputum.
    Int J Antimicrob Agents. 2020 Jan 10:105898.
    PubMed     Text format     Abstract available

  24. DA SILVA BNM, Faria AR, de Souza SDSR, Colodette SS, et al
    Expression of VanA-type vancomycin resistance in a clinical isolate of Enterococcus faecium showing insertion of IS19 in the vanS gene.
    Int J Antimicrob Agents. 2020 Jan 10:105897.
    PubMed     Text format     Abstract available


    J Antimicrob Chemother

  25. ROGERS VAN KATWYK S, Grimshaw JM, Nkangu M, Mendelson M, et al
    Study reporting quality among interventions to reduce antibiotic use is a barrier to evidence-informed policymaking on antimicrobial resistance: systematic review.
    J Antimicrob Chemother. 2020 Jan 16. pii: 5707357. doi: 10.1093.
    PubMed     Text format     Abstract available

  26. PAINSET A, Day M, Doumith M, Rigby J, et al
    Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Campylobacter jejuni and Campylobacter coli isolated from cases of diarrhoeal disease in England and Wales, 2015-16.
    J Antimicrob Chemother. 2020 Jan 16. pii: 5707358. doi: 10.1093.
    PubMed     Text format     Abstract available

  27. GAUTHIER L, Dortet L, Jousset AB, Mihaila L, et al
    Molecular characterization of plasmid-encoded Tripoli MBL 1 (TMB-1) in Enterobacteriaceae.
    J Antimicrob Chemother. 2019;74:42-47.
    PubMed     Text format     Abstract available

  28. XHEMALI X, Smith JR, Kebriaei R, Rice SA, et al
    Evaluation of dalbavancin alone and in combination with beta-lactam antibiotics against resistant phenotypes of Staphylococcus aureus.
    J Antimicrob Chemother. 2018 Sep 27. pii: 5107805. doi: 10.1093.
    PubMed     Text format     Abstract available

  29. CHAPLIN B, Akanmu AS, Inzaule SC, Samuels JO, et al
    Association between HIV-1 subtype and drug resistance in Nigerian infants.
    J Antimicrob Chemother. 2019;74:172-176.
    PubMed     Text format     Abstract available

  30. HIRSCH R, Wiesner J, Marker A, Pfeifer Y, et al
    Profiling antimicrobial peptides from the medical maggot Lucilia sericata as potential antibiotics for MDR Gram-negative bacteria.
    J Antimicrob Chemother. 2019;74:96-107.
    PubMed     Text format     Abstract available

  31. KEITA A, Sereme Y, Pillet S, Coulibaly S, et al
    Impact of HIV-1 primary drug resistance on the efficacy of a first-line antiretroviral regimen in the blood of newly diagnosed individuals in Bamako, Mali.
    J Antimicrob Chemother. 2019;74:165-171.
    PubMed     Text format     Abstract available

  32. O'GRADY MC, Barry L, Corcoran GD, Hooton C, et al
    Empirical treatment of urinary tract infections: how rational are our guidelines?
    J Antimicrob Chemother. 2018 Oct 8. pii: 5123549. doi: 10.1093.
    PubMed     Text format     Abstract available

  33. SO W, Shurko J, Galega R, Quilitz R, et al
    Mechanisms of high-level ceftolozane/tazobactam resistance in Pseudomonas aeruginosa from a severely neutropenic patient and treatment success from synergy with tobramycin.
    J Antimicrob Chemother. 2019;74:269-271.
    PubMed     Text format    

  34. YAN J, Xue J, Chen Y, Chen S, et al
    Increasing prevalence of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone and resistance to azithromycin in Hangzhou, China (2015-17).
    J Antimicrob Chemother. 2019;74:29-37.
    PubMed     Text format     Abstract available

  35. YU Y, Walsh TR, Yang RS, Zheng M, et al
    Novel partners with colistin to increase its in vivo therapeutic effectiveness and prevent the occurrence of colistin resistance in NDM- and MCR-co-producing Escherichia coli in a murine infection model.
    J Antimicrob Chemother. 2019;74:87-95.
    PubMed     Text format     Abstract available

  36. WHITNEY L, Al-Ghusein H, Glass S, Koh M, et al
    Effectiveness of an antifungal stewardship programme at a London teaching hospital 2010-16.
    J Antimicrob Chemother. 2019;74:234-241.
    PubMed     Text format     Abstract available


    J Infect Dis

  37. GRILLOVA L, Noda AA, Lienhard R, Blanco O, et al
    Multilocus sequence typing of Treponema pallidum subsp. pallidum in Cuba from 2012 to 2017.
    J Infect Dis. 2018 Oct 16. pii: 5132979. doi: 10.1093.
    PubMed     Text format     Abstract available

  38. FINBERG RW, Lanno R, Anderson D, Fleischhackl R, et al
    Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial.
    J Infect Dis. 2018 Nov 14. pii: 5183286. doi: 10.1093.
    PubMed     Text format     Abstract available


    PLoS One

  39. MEKONNEN B, Mihret A, Getahun M, Hailu T, et al
    Evaluation of the tuberculosis culture color plate test for rapid detection of drug susceptible and drug-resistant Mycobacterium tuberculosis in a resource-limited setting, Addis Ababa, Ethiopia.
    PLoS One. 2019;14:e0215679.
    PubMed     Text format     Abstract available

  40. SAN MARTIN B, Fresno M, Cornejo J, Godoy M, et al
    Optimization of florfenicol dose against Piscirickettsia salmonis in Salmo salar through PK/PD studies.
    PLoS One. 2019;14:e0215174.
    PubMed     Text format     Abstract available

  41. PETERS L, Olson L, Khu DTK, Linnros S, et al
    Multiple antibiotic resistance as a risk factor for mortality and prolonged hospital stay: A cohort study among neonatal intensive care patients with hospital-acquired infections caused by gram-negative bacteria in Vietnam.
    PLoS One. 2019;14:e0215666.
    PubMed     Text format     Abstract available

  42. COSTA VD, Brandao-Mello CE, Nunes EP, Dos Santos Silva PGC, et al
    Treatment of chronic HCV infection with DAAs in Rio de Janeiro/Brazil: SVR rates and baseline resistance analyses in NS5A and NS5B genes.
    PLoS One. 2019;14:e0216327.
    PubMed     Text format     Abstract available

  43. COHEN DB, Davies G, Malwafu W, Mangochi H, et al
    Poor outcomes in recurrent tuberculosis: More than just drug resistance?
    PLoS One. 2019;14:e0215855.
    PubMed     Text format     Abstract available

  44. COLMAN AM, Krockow EM, Chattoe-Brown E, Tarrant C, et al
    Medical prescribing and antibiotic resistance: A game-theoretic analysis of a potentially catastrophic social dilemma.
    PLoS One. 2019;14:e0215480.
    PubMed     Text format     Abstract available


    Sex Transm Infect

  45. PITT R, Unemo M, Sonnenberg P, Alexander S, et al
    Antimicrobial resistance in Mycoplasma genitalium sampled from the British general population.
    Sex Transm Infect. 2020 Jan 10. pii: sextrans-2019-054129.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: